Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Grahaprima Suksesmandiri Tbk. (GTRA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Grahaprima Suksesmandiri Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Grahaprima Suksesmandiri Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Grahaprima Suksesmandiri Tbk. trades at Rp212 (market cap 416.76B, 108.5K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp150 (market cap 576.7B, 2.33M 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (2.33M versus 108.5K). Which is the better fit depends on your goals.

GTRALABS
Market Cap
416.76B576.7B
Volume
108.5K2.33M
Lot
1.09K23.32K
Turnover
23.33M353.41M
Average Price
215.02151.55
Value
23.33M353.41M
Indicative Equilibrium Price
222147
Indicative Equilibrium Volume
82311

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GTRA
View details
LABS
View details

About Grahaprima Suksesmandiri Tbk.

PT Grahaprima Suksesmandiri Tbk (the “Company”) was established on August 11, 2004 based onNotarial Deed No. 15 of Hermanto, S.H., notary in Bekasi. The Company started its commercial operations on 2006.

Read more on GTRA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS